in vitro News and Research

RSS

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

Researchers evaluated the infectivity of two SARS-CoV-2 A lineage variants on human ocular tissues in vitro.

1 Aug 2022

Nanoparticles' toxic effects on macrophages

Researchers summarize the toxic effects of nanoparticles on macrophages in vitro.

31 Jul 2022

Is cannabidiol effective against COVID-19?

A new study discusses the utility of CBD in treating the inflammatory symptoms of COVID-19

31 Jul 2022

Study shows the link between common viruses and onset of Alzheimer’s disease

Alzheimer's disease can begin almost imperceptibly, often masquerading in the early months or years as forgetfulness that is common in older age. What causes the disease remains largely a mystery.

29 Jul 2022

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

A new class of glioma drugs exploits tumors that lack the DNA repair enzyme MGMT; the drugs lead to the generation of cytotoxic DNA and selectively kill tumor cells without the risk of resistance, researchers report.

29 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

A study by the Geneva University Hospitals (HUG), the Faculty of Medicine of the University of Geneva and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2, almost three quarters of whom acquired them through an infection.

28 Jul 2022

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

Researchers found that vaccinated people were at an increased risk of infection with SARS-CoV-2 Beta, Gamma, or Delta variants.

28 Jul 2022

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

Researchers assessed the effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant.

28 Jul 2022

Mesoporous silica nanoparticles: Possibilities in therapeutic development

In this interview, News-Medical talks to Philippe Riviere, Senior Scientist at NanoComposix (now a Fortis Life Sciences company) about mesoporous silica nanoparticles and the possibilities and opportunities they provide to drug delivery, vaccine development and more.

From nanoComposix 28 Jul 2022

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

When all else fails, some patients trying to overcome alcoholism, severe depression or anxiety, and even cluster headaches, turn to psychedelic drugs, which clinical research has shown can help treat individuals with these conditions, sometimes with dramatically positive results.

27 Jul 2022

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Researchers evaluate the neutralizing potency of therapeutic monoclonal antibodies against three sub-lineages of the SARS-CoV-2 Omicron variant.

27 Jul 2022

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Researchers depicted the correlations between receptor-binding domain (RBD)-selective proliferative memory CD4 T cells and neutralizing antibodies in COVID-19 vaccinees and convalescent patients.

27 Jul 2022

Genetic variations in serotonin receptor causes different response to psychedelic drugs

Cluster headaches, anxiety and depression can be debilitating for people living with these conditions. Psychedelic drugs have shown benefits as treatments for these conditions in clinical studies, but not for everyone.

27 Jul 2022

FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), today announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that provides the ideal balance between ease of use and protection.

From FUJIFILM Irvine Scientific 27 Jul 2022

in vitro News and Research

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

Nanoparticles' toxic effects on macrophages

Is cannabidiol effective against COVID-19?

Study shows the link between common viruses and onset of Alzheimer’s disease

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

Tannins as therapeutic agents against SARS-CoV-2

New glioma drug may represent a paradigm for designing therapeutics exploiting specific DNA repair

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

Mesoporous silica nanoparticles: Possibilities in therapeutic development

Genetic variations in one serotonin receptor could be the reason behind psychedelic treatment disparity

Efficacy of monoclonal antibodies against Omicron BA.1, BA.2, and BA.5

Scientists explore associations between SARS-CoV-2 neutralizing antibodies and receptor-binding domain-selective proliferative memory CD4 T cells

Genetic variations in serotonin receptor causes different response to psychedelic drugs

FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Differences in development of children conceived by ART are no longer apparent by late adolescence

Tunneling nanotubes can assist SARS-CoV-2 propagation

Driving innovation in drug discovery with in vitro biology solutions eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News